Index of artpub/2017/196266/

Hájek, R
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
2017
https://ddd.uab.cat/record/196266